Lantern Pharma is trading 7.7% up at $1.83, after closing at $1.70 on September 15, 2026; the reason remains unconfirmed.
- No company-specific announcement dated September 16 was identified; latest notable updates were the August 3 Open-Medicine AI separation and August 14 second-quarter results.
- Biotech-sector weakness does not explain the gain, while major indexes are mixed.
- The move may reflect low-liquidity trading or an undisclosed catalyst.